Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2

Human Molecular Genetics

Volumn 11, Issue 6, 2002, Pages 661-667

  Alkhateeb, Asem ^a   Stetler, Gary L ^a   Old, William ^a   Talbert, Janet ^a   Uhlhorn, Cynthia ^a   Taylor, Melanie ^a   Fox, Angela ^a   Miller, Cynthia ^a   Dills, Diana G ^a   Ridgway, E Chester ^a   Bennett, Dorothy C ^b   Fain, Pamela R ^a   Spritz, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME 1P; CHROMOSOME 6P; CHROMOSOME MARKER; CLUSTER ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; GENE LOCUS; GENE MAPPING; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HASHIMOTO DISEASE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; THYROID DISEASE; VITILIGO;

EID: 18344388283     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.6.661     Document Type: Article

References (37)

1. Autoimmune disease: Why and where it occurs
2. Autoimmunity and vitiligo
3. Vitiligo vulgaris
4. Vitiligo
5. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
6. Inherited Abnormalities of the Skin and Appendages
7. Heredity of acquired vitiligo (vitiligo in three generations)
8. Epidemiological study of vitiligo in Surat area
9. Analisis genetico de 127 familias con vitiligo
10. The genetics of vitiligo
11. Studies on vitiligo. II. Familial aggregation and genetics
12. A genetical model for vitiligo
13. Pattern of familial aggregation of vitiligo
14. Genetic nature of vitiligo
15. Genetic epidemiology of vitiligo: Multilocus recessivity cross-validated
16. Vitiligo in a pair of monovular twins
17. Die Zwillingspathologie der Vitiligo
18. Immunologic aspects of endocrine diseases
19. Autoimmune polyglandular syndromes
20. Autoimmune polyendocrine syndrome type II
21. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of cell-mediated vitiligo
22. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration
23. The Colorado thyroid disease prevalence study
24. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
25. Prevalence of vitiligo: Epidemiological survey on the Isle of Bornholm, Denmark
26. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions
27. Linkage and association of HLA class II genes with vitiligo in a Dutch population
28. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: Replication using a population case control and family-based study
29. *08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective
30. The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African
31. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement
32. Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay
33. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma
34. PedCheck: A program for identification of genotype incompatibilities in linkage analysis
35. Faster sequential genetic linkage computations
36. Parametric and nonparametric linkage analysis: A unified multipoint approach
37. Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and marker sharing statistics